Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge.

MLA

Alberca, Berta, et al. “Vaccination of Horses with a Recombinant Modified Vaccinia Ankara Virus (MVA) Expressing African Horse Sickness (AHS) Virus Major Capsid Protein VP2 Provides Complete Clinical Protection against Challenge.” Vaccine, vol. 32, no. 29, June 2014, pp. 3670–74. EBSCOhost, https://doi.org/10.1016/j.vaccine.2014.04.036.

APA

Alberca, B., Bachanek-Bankowska, K., Cabana, M., Calvo-Pinilla, E., Viaplana, E., Frost, L., Gubbins, S., Urniza, A., Mertens, P., & Castillo-Olivares, J. (2014). Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge. Vaccine, 32(29), 3670–3674. https://doi.org/10.1016/j.vaccine.2014.04.036

Chicago

Alberca, Berta, Katarzyna Bachanek-Bankowska, Marta Cabana, Eva Calvo-Pinilla, Elisenda Viaplana, Lorraine Frost, Simon Gubbins, Alicia Urniza, Peter Mertens, and Javier Castillo-Olivares. 2014. “Vaccination of Horses with a Recombinant Modified Vaccinia Ankara Virus (MVA) Expressing African Horse Sickness (AHS) Virus Major Capsid Protein VP2 Provides Complete Clinical Protection against Challenge.” Vaccine 32 (29): 3670–74. doi:10.1016/j.vaccine.2014.04.036.